mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-09 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
1e-08 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-08 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-08 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.28 |
1e-07 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-07 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
4e-07 |